Week 4 - Shock & MODS Flashcards
(129 cards)
Shock
- Syndrome characterized by decreased tissue __________ and impaired cellular __________
- Imbalance in supply/demand for ___ and nutrients
Shock
- Syndrome characterized by decreased tissue perfusion and impaired cellular metabolism
- Imbalance in supply/demand for O2 and nutrients
Categories of Shock
-Hypovolemic Shock [absolute or relative]
-Cardiogenic Shock
-Obstructive shock
Distributive shock—
-Septic Shock
-Anaphylactic Shock
-Neurogenic Shock
-Hypovolemic Shock [absolute or relative]
-Cardiogenic Shock
-Obstructive shock
Distributive shock—
-Septic Shock
-Anaphylactic Shock
-Neurogenic Shock
Classifications of Shock
Low _________
- Cardiogenic
- Hypovolemic
Maldistribution/___________
- Septic
- Anaphylactic
- Neurogenic
Low blood flow
- Cardiogenic
- Hypovolemic
Maldistribution/Distributive
- Septic
- Anaphylactic
- Neurogenic
Low Blood Flow - Hypovolemic Shock
- Absolute hypovolemia: loss of __________ fluid volume
- Hemorrhage
- GI loss (e.g. severe vomiting, diarrhea)
- Diabetes insipidus
- Diuresis
- Absolute hypovolemia: loss of intravascular fluid volume
- Hemorrhage
- GI loss (e.g. severe vomiting, diarrhea)
- Diabetes insipidus
- Diuresis
Low Blood Flow - Hypovolemic Shock
- Relative hypovolemia
Results when fluid volume moves out of the vascular space into _____________ space (e.g., interstitial or intracavitary space)
– i.e. burns, ascitis, internal bleed
- Relative hypovolemia
Results when fluid volume moves out of the vascular space into extravascular space (e.g., interstitial or intracavitary space)
– i.e. burns, ascitis, internal bleed
Clinical Manifestations - Hypovolemic Shock
- _________ in BP, PP, SV, PAWP, CVP, CO
- ________ HR, SVR
- Decrease in UO
- Decrease SvO2/ScvO2
- Tachypnea
- Cool and diaphoretic
- Anxious, confused, agitated
- Decrease in BP, PP, SV, PAWP, CVP, CO
- Increase HR, SVR
- Decrease in UO
- Decrease SvO2/ScvO2
- Tachypnea
- Cool and diaphoretic
- Anxious, confused, agitated
Diagnostic Findings - Hypovolemic Shock
- CBC
- Electrolyte levels (eg, Na, K, Cl, HCO3, BUN,
creatinine, glucose levels)
- Prothrombin time, activated partial thromboplastin time
- ABGs
- Urinalysis (specific gravity)
- Blood type and cross-match
- Lactate levels
- CBC
- Electrolyte levels (eg, Na, K, Cl, HCO3, BUN,
creatinine, glucose levels) - Prothrombin time, activated partial thromboplastin time
- ABGs
- Urinalysis (specific gravity)
- Blood type and cross-match
- Lactate levels
Collaborative Care - Hypovolemic Shock
- Overall management goal: focus on stopping the loss of fluid and restoring ________
- Airway and oxygenation
- 2 large bore IV’s (16 Gauge)
- Fluid replacement (crystalloids or colloids)
- Possible: Arterial line
- Specific meds based on etiology
- Overall management goal: focus on stopping the loss of fluid and restoring volume
- Airway and oxygenation
- 2 large bore IV’s (16 Gauge)
- Fluid replacement (crystalloids or colloids)
- Possible: Arterial line
- Specific meds based on etiology
Low Blood Flow - Cardiogenic Shock - Precipitating causes:
- Primary ventricular ischemia
– ___ being most common cause - Structural problems
- Sustained dysrhythmias
- Primary ventricular ischemia
– MI being most common cause - Structural problems
- Sustained dysrhythmias
Clinical Manifestations - Cardiogenic Shock
- _________ in CO, BP, PP, UO
- _________in Myocardial O2 consumption, HR, SVR, PVR, PAWP, CVP
- Decrease in SvO2/ScvO2
- Tachypnea, pulmonary congestion
- Pallor, cool, clammy skin
- Anxiety, confusion, agitation
- Decrease in CO, BP, PP, UO
- Increase in Myocardial O2 consumption, HR, SVR, PVR, PAWP, CVP
- Decrease in SvO2/ScvO2
- Tachypnea, pulmonary congestion
- Pallor, cool, clammy skin
- Anxiety, confusion, agitation
Diagnostic Findings - Cardiogenic Shock
- CBC, Chem panel, Coag Panel
- Cardiac biomarkers
- ABG
- Lactate
- ECG: Dysrhythmias
- ECHO: Left ventricular dysfunction
- CXR: Pulmonary infiltrates
- CBC, Chem panel, Coag Panel
- Cardiac biomarkers
- ABG
- Lactate
- ECG: Dysrhythmias
- ECHO: Left ventricular dysfunction
- CXR: Pulmonary infiltrates
Collaborative Care - Cardiogenic Shock
- Correct _________ & ________ abnormalities
- _____________ monitoring (PA and art lines)
- Drug therapy
-Improve preload - Reduce afterload
- Improve contractility
- Circulatory assist devices (e.g., intra-aortic balloon pump, ventricular assist device)
- Correct electrolyte and acid-base abnormalities
- Hemodynamic monitoring (PA and art lines)
- Drug therapy
-Improve preload - Reduce afterload
- Improve contractility
- Circulatory assist devices (e.g., intra-aortic balloon pump, ventricular assist device)
Collaborative Care - Cardiogenic Shock
- Oxygenation and _______ protection
- Restore blood flow to the _________
- Thrombolytic therapy (t-PA)
- Emergency revascularization
- CABG or valve replacement
- Oxygenation and airway protection
- Restore blood flow to the myocardium
- Thrombolytic therapy (t-PA)
- Emergency revascularization
- CABG or valve replacement
Maldistribution of Blood Flow - Septic Shock
- Sepsis: is a life threatening organ dysfunction caused by dysregulated _______________________________
- Septic shock: ____________ despite fluid replacement; need vasopressors to keep MAP ≥ to 65 mmHg
- Sepsis: is a life threatening organ dysfunction caused by dysregulated host response to infection
- Septic shock: hypotension despite fluid replacement; need vasopressors to keep MAP ≥ to 65 mmHg
Sepsis Screening
SIRS Criteria:
- High or low temperature > 38 or < 36
- Heart Rate > __ bpm
- Respiratory Rate > ___ or PaCO2 < 32 mm Hg
- WBC’s >12 or < 4 , or with > 10% bands
Q SOFA Score of 2 or greater
- Altered mental status (GCS score <15)
- Systolic blood pressure <100 mmHg
- Respiratory rate >22/min
SIRS Criteria:
- High or low temperature > 38 or < 36
- Heart Rate > 90 bpm
- Respiratory Rate > 20min or PaCO2 < 32 mm Hg
- WBC’s >12 or < 4 , or with > 10% bands
Q SOFA Score of 2 or greater
- Altered mental status (GCS score <15)
- Systolic blood pressure <100 mmHg
- Respiratory rate >22/min
Clinical Manifestations - Septic Shock
- Increased HR, RR
- Decreased BP, PP, SVR, CVP, PAWP
- Decreased CO, SvO2/ScvO2
- Temperature dysregulation
- ↓ Urine output
- Altered neurologic status, GI dysfunction, respiratory failure, myocardial dysfunction
- Increased HR, RR
- Decreased BP, PP, SVR, CVP, PAWP
- Decreased CO, SvO2/ScvO2
- Temperature dysregulation
- ↓ Urine output
- Altered neurologic status, GI dysfunction, respiratory failure, myocardial dysfunction
Diagnostic Findings - Septic Shock
- CBC: Increase or decrease in _____ and decreased _____
- Increased ______ levels
- Positive cultures (urine, sputum, blood)
- CBC: Increase or decrease in WBC’s and decreased platelets
- Increased lactate levels
- Positive cultures (urine, sputum, blood)
Collaborative Care - Septic Shock
- Surviving Sepsis 2018 bundle (1-3 hours)
- Measure ________, re-measure if elevated
- Pan culture and give ___________ as early as possible
- Fluid resuscitate for hypotension or lactate > 4; ___________ are preferred
- Goal CVP 8-12 mm Hg
- Urine output > 0.5ml/kg/hr & lungs clear
- Start vasopressors for hypotension refractory to fluids
- (e.g. Dopamine, norepinephrine [Levophed])
- Consider transfer to the ICU
- Surviving Sepsis 2018 bundle (1-3 hours)
- Measure lactate, re-measure if elevated
- Pan culture and give antibiotics as early as possible
- Fluid resuscitate for hypotension or lactate > 4; crystalloids are preferred
- Goal CVP 8-12 mm Hg
- Urine output > 0.5ml/kg/hr & lungs clear
- Start vasopressors for hypotension refractory to fluids
- (e.g. Dopamine, norepinephrine [Levophed])
- Consider transfer to the ICU
Collaborative Care - Septic Shock
- Hemodynamic monitoring (CLC with CVP and ScVO2 monitoring)
- Protective lung ventilation (low tidal volumes w/ pressure control)
- IV corticosteroids**
- Hemodynamic monitoring (CLC with CVP and ScVO2 monitoring)
- Protective lung ventilation (low tidal volumes w/ pressure control)
- IV corticosteroids**
Maldistribution of Blood Flow - Anaphylactic Shock
- Acute, life-threatening hypersensitivity reaction to a sensitizing substance
- Massive __________ (circulatory collapse)
- Release of vasoactive mediators
- ↑ Capillary __________
- Respiratory distress (Bronchospasm, laryngeal edema)
- Acute, life-threatening hypersensitivity reaction to a sensitizing substance
- Massive vasodilatation (circulatory collapse)
- Release of vasoactive mediators
- ↑ Capillary permeability
- Respiratory distress (Bronchospasm, laryngeal edema)
Clinical Manifestations - Anaphylactic Shock
- Sudden and worsens on _______ exposure
- Uneasy, apprehensive, anxious, impending doom
- Itching, flushing, urticaria (hives), angioedema
- Bronchoconstriction, excessive mucous, wheezing, stridor—laryngeal edema—
hypoxemia - Increase in __
- Decrease in __, PP, SVR, CVP, PAWP, CO, SvO2/ScvO2
- Sudden and worsens on repeat exposure
- Uneasy, apprehensive, anxious, impending doom
- Itching, flushing, urticaria (hives), angioedema
- Bronchoconstriction, excessive mucous, wheezing, stridor—laryngeal edema—
hypoxemia - Increase in HR
- Decrease in BP, PP, SVR, CVP, PAWP, CO, SvO2/ScvO2
Collaborative Care - Anaphylactic Shock
- Maintaining a patent _______
- Oxygen
- Endotracheal intubation or tracheotomy
- Nebulized bronchodilators
- ________ine
- Diphenhydramine (Benadryl)
- Aggressive _____ replacement
- Maintaining a patent airway
- Oxygen
- Endotracheal intubation or tracheotomy
- Nebulized bronchodilators
- Epinephrine
- Diphenhydramine (Benadryl)
- Aggressive fluid replacement
Maldistribution of Blood Flow - Neurogenic Shock
Hemodynamic phenomenon that can occur within 30 minutes of a ____________ injury at the fifth thoracic (T5) vertebra or above and can last up to 6 weeks
Can be in response to spinal __________
Results in massive vasodilation leading to pooling of _________ in __________
Hemodynamic phenomenon that can occur within 30 minutes of a spinal cord injury at the fifth thoracic (T5) vertebra or above and can last up to 6 weeks
Can be in response to spinal anesthesia
Results in massive vasodilation leading to pooling of blood in vessels
Clinical Manifestations - Neurogenic Shock
- _________ in BP, PP, SVR, CVP, PAWP, CO, SvO2/ScvO2, bladder dysfunction
- Bradycardia**
- Dry skin**
- Temperature dysregulation (resulting in heat loss)**
- Poikilothermia (taking on the temperature of the environment)
- Decrease in BP, PP, SVR, CVP, PAWP, CO, SvO2/ScvO2, bladder dysfunction
- Bradycardia**
- Dry skin**
- Temperature dysregulation (resulting in heat loss)**
- Poikilothermia (taking on the temperature of the environment)